The National Institutes of Health (NIH) is announcing the availability of a government-owned invention for licensing. This invention involves monoclonal antibodies that can neutralize Epstein-Barr virus (EBV), which causes infectious mononucleosis and various cancers. These antibodies offer potential uses in diagnostics, therapeutics, and vaccine research. Interested parties can contact Peter Soukas for licensing opportunities or collaborative research to further develop and commercialize this technology.
Simple Explanation
The NIH has a special tool that can help fight a virus that makes people sick and can also lead to cancer. They are looking for people who want to work with them to test and use this tool to help others.